Ligand Pharmaceuticals LGND Less: Net increase (decrease) in cash classified within assets held for sale

Less: Net increase (decrease) in cash classified within assets held for sale at other companies

Carrier GlobalCARR

$43M—

GE VernovaGEV

-$2M—

3MMMM

$3M—

Ready CapitalRC

$0+100%

Tapestry, Inc.TPR

$5.93M—

Landstar SystemLSTR

-$136K—

Other financials

Income statement

See full

Revenue$51.7M+14.1%

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

See full

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

See full

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

See full

Market cap$5.6B+96.7%

Profitability

See full

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

See full

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffectDisposalGroupIncludingDiscontinuedOperations.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's less: net increase (decrease) in cash classified within assets held for sale.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ligand Pharmaceuticals's less: net increase (decrease) in cash classified within assets held for sale?: Ligand Pharmaceuticals (LGND) reported less: net increase (decrease) in cash classified within assets held for sale of $0 in Q1 2026.
How has Ligand Pharmaceuticals's less: net increase (decrease) in cash classified within assets held for sale changed year-over-year?: Ligand Pharmaceuticals's less: net increase (decrease) in cash classified within assets held for sale increased by 100.0% year-over-year, from -$78K to $0.